| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.1990.8.2.330 |
| P698 | PubMed publication ID | 2153766 |
| P50 | author | Diane Lynn Fairclough | Q106415142 |
| P2093 | author name string | R A Sanford | |
| J W Langston | |||
| J J Jenkins | |||
| E H Kovnar | |||
| M E Horowitz | |||
| R K Mulhern | |||
| E C Douglass | |||
| S J Kellie | |||
| E E Etcubanas | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cisplatin | Q412415 |
| Embryonal tumors of the central nervous system | Q104658983 | ||
| etoposide | Q418817 | ||
| medulloblastoma | Q1333608 | ||
| P304 | page(s) | 330-336 | |
| P577 | publication date | 1990-02-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study | |
| P478 | volume | 8 |
| Q33344066 | Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children |
| Q41650694 | Adjuvant Chemotherapy of Pediatric Brain Tumors |
| Q33396889 | Adult medulloblastoma: multiagent chemotherapy with cisplatinum and etoposide: a single institutional experience. |
| Q80510573 | Biology and therapy of malignant solid tumors in childhood |
| Q41586570 | Brain tumors. Challenges and directions |
| Q41118775 | Chemotherapy for medulloblastomas and primitive neuroectodermal tumors |
| Q41692235 | Chemotherapy for pediatric brain tumors |
| Q37713662 | Childhood medulloblastoma: current status of biology and treatment |
| Q33383165 | Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors |
| Q48497281 | Cisplatin/vincristine chemotherapy for hypothalamic/visual pathway astrocytomas in young children |
| Q41735764 | Current therapy and new perspectives in the treatment of medulloblastoma |
| Q38112088 | Effective childhood cancer treatment: the impact of large scale clinical trials in Germany and Austria |
| Q42053240 | Etoposide-carboplatin association as 'emergency' up-front chemotherapy in a case of life-threatening adult medulloblastoma |
| Q48172571 | Harvesting blood stem cells from cranial bone at craniotomy--a preliminary study |
| Q31418305 | High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors |
| Q43605305 | Intra-arterial cisplatin plus oral etoposide for the treatment of recurrent malignant glioma: a phase II study |
| Q55476192 | Medulloblastoma--challenges in radiation therapy and the addition of chemotherapy. |
| Q30983559 | Medulloblastoma: I. Clinical, diagnostic, and therapeutic overview |
| Q48527609 | Neuraxis dissemination in pediatric brain tumors. Response to preirradiation chemotherapy |
| Q55478301 | Patterns of failure in children with medulloblastoma: Effects of preirradiation chemotherapy |
| Q33780411 | Phase 1 study of an oxaliplatin and etoposide regimen in pediatric patients with recurrent solid tumors |
| Q55475451 | Preirradiation ifosfamide, carboplatin, and etoposide for the treatment of anaplastic astrocytomas and glioblastoma multiforme: a phase II study. |
| Q48391650 | Prognosis of intracranial germ cell tumours: Effectiveness of chemotherapy with cisplatin and etoposide (CDDP and VP-16) |
| Q43636013 | Prolonged second response to cisplatin, etoposide, and ifosfamide in a child with a recurrent brainstem glioblastoma |
| Q50115714 | Response of brain tumors to chemotherapy, evaluated in a clinically relevant xenograft model |
| Q37873471 | Risk-adapted chemotherapy in childhood medulloblastoma |
| Q41131696 | Strategies in the treatment of diffuse pontine gliomas: the therapeutic role of hyperfractionated radiotherapy and chemotherapy |
| Q44211448 | The DNA damaging agent etoposide activates a cell survival pathway involving alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptors and mitogen-activated protein kinases in hippocampal neurons |
| Q33703149 | The role of surgery in pediatric gliomas |
| Q40629659 | Treatment of intracranial nongerminomatous germ-cell tumor by high-dose chemotherapy and autologous stem-cell rescue |
| Q55478599 | Treatment of recurrent malignant supratentorial gliomas with the association of carboplatin and etoposide: a phase II study. |
| Q34399296 | What have we learnt from previous phase II trials to help in the management of childhood brain tumours? |
| Q33496229 | Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma? |
Search more.